Valeant Pharmaceuticals approved to buy Dendreon for $495 million
February 20, 2015 at 19:19 PM EST
Quebec-based Valeant Pharmaceuticals received approval from a bankruptcy court judge today to buy the assets of Dendreon Corp...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.